Literature DB >> 25016479

Laser therapy versus observation for symptomatic retinal artery macroaneurysms.

Jacob C Meyer1, Baseer U Ahmad, Kevin J Blinder, Gaurav K Shah.   

Abstract

PURPOSE: The optimal management approach to retinal arterial macroaneurysms (RAM) is unknown. This paper compares long-term outcomes in RAM treated with laser therapy versus observation.
METHODS: This is an IRB-approved retrospective study of patients with symptomatic RAM. Charts of patients with a diagnosis of RAM causing symptomatic visual loss were reviewed. Patients with less than 6 months follow up, other confounding diagnoses, or additional therapy beyond thermal laser were excluded. Statistical analysis was done using χ(2) or Student's t test as appropriate.
RESULTS: Forty-eight patients with RAM were identified and 27 were included in the study (13 treated, 14 observed). Mean visual acuity in the observation group improved from 20/120 to 20/96 (p = 0.53) compared to 20/280 to 20/54 (p = 0.0003) in the treated group. Subgroup analysis showed that visual acuity in primarily hemorrhagic lesions treated with laser therapy improved by 1.21 logMAR compared to a loss of 0.11 logMAR (p = 0.002) in those that were observed. In primarily exudative lesions, both treated and observed lesions showed an improvement of 0.32 logMAR. No patients in the treatment group had a final visual acuity below 20/200 compared to four in the observation group.
CONCLUSION: Treatment with direct laser photocoagulation was associated in this study with greater improvement in visual acuity and may decrease the risk of severe visual loss especially in primarily hemorrhagic RAM lesions. Compared to observation alone.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25016479     DOI: 10.1007/s00417-014-2730-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  19 in total

1.  Branch retinal vein occlusion after spontaneous obliteration of retinal arterial macroaneurysm.

Authors:  M Battaglia Parodi; E Bondel; S Saviano; G Ravalico
Journal:  Retina       Date:  1998       Impact factor: 4.256

2.  Options in the treatment of macular diseases.

Authors:  J D Gass
Journal:  Trans Ophthalmol Soc U K       Date:  1972

3.  Acquired arterial macroaneurysms of the retina.

Authors:  R A Lewis; E W Norton; J D Gass
Journal:  Br J Ophthalmol       Date:  1976-01       Impact factor: 4.638

4.  Intravitreal bevacizumab for symptomatic retinal arterial macroaneurysm.

Authors:  Han Joo Cho; Taek Kwan Rhee; Hyoung Seok Kim; Jung Il Han; Dong Won Lee; Sung Won Cho; Jong Woo Kim
Journal:  Am J Ophthalmol       Date:  2013-02-04       Impact factor: 5.258

5.  Macroaneurysms of the retinal arteries.

Authors:  A G Palestine; D M Robertson; B G Goldstein
Journal:  Am J Ophthalmol       Date:  1982-02       Impact factor: 5.258

6.  Retinal arterial macroaneurysms: a retrospective study of 40 patients.

Authors:  M J Lavin; R J Marsh; S Peart; A Rehman
Journal:  Br J Ophthalmol       Date:  1987-11       Impact factor: 4.638

7.  Ruptured retinal arterial macroaneurysm associated with a stage IV macular hole.

Authors:  Antonio P Ciardella; Gaetano Barile; William Schiff; Lucian Del Priore; Kevin Langton; Stanley Chang
Journal:  Am J Ophthalmol       Date:  2003-06       Impact factor: 5.258

8.  Retinal arterial macroaneurysms: risk factors and natural history.

Authors:  R W Panton; M F Goldberg; M D Farber
Journal:  Br J Ophthalmol       Date:  1990-10       Impact factor: 4.638

9.  Retinal arteriolar macroaneurysms: long-term visual outcome.

Authors:  D M Brown; W M Sobol; J C Folk; T A Weingeist
Journal:  Br J Ophthalmol       Date:  1994-07       Impact factor: 4.638

10.  Macular hole formation after macular haemorrhage associated with rupture of retinal arterial macroaneurysm.

Authors:  N Sagara; T Kawaji; Y Koshiyama; Y Inomata; M Fukushima; H Tanihara
Journal:  Br J Ophthalmol       Date:  2009-06-10       Impact factor: 4.638

View more
  5 in total

1.  Longitudinal characterization and treatment response of retinal arterial macroaneurysms in adult-onset coats disease.

Authors:  Amisha D Dave; Alisa T Thavikulwat; Tharindu De Silva; Henry E Wiley; Tiarnan D L Keenan; Wai T Wong; Catherine A Cukras
Journal:  Am J Ophthalmol Case Rep       Date:  2022-07-01

2.  Foveal Exudative Macroaneurysm Treated with Intravitreal Ranibizumab.

Authors:  Carlos Menezes; Rui Carvalho; Carla Teixeira; José Alberto Lemos; Rita Gonçalves; Pedro Coelho; André Lima
Journal:  Case Rep Ophthalmol       Date:  2015-06-02

3.  Serial bevacizumab injections and laser photocoagulation for macular edema associated with a retinal artery macroaneurysm.

Authors:  Ella H Leung; Ashvini K Reddy; Anil S Vedula; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2015-04-04

4.  Outcomes of combined treatments in patients with retinal arterial macroaneurysm.

Authors:  Chenghu Wang; Guofan Cao; Xiangzhong Xu; Jian Wang; Shu Zhang
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

5.  Optical coherence tomography (OCT) angiography findings in retinal arterial macroaneurysms.

Authors:  Maged Alnawaiseh; Friederike Schubert; Pieter Nelis; Gabriele Wirths; André Rosentreter; Nicole Eter
Journal:  BMC Ophthalmol       Date:  2016-07-22       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.